PolyPeptide names new CEO before likely Swiss IPO during 2021

ZURICH (Reuters) - Privately held drug industry contract manufacturer PolyPeptide Group named a new chief executive on Tuesday ahead of a likely initial public offering (IPO) in Switzerland later this year. Raymond De Vre, a Belgian who previously worked at Indian contract manufacturer Dr. Reddy's Laboratories as global head of biologics, will join PolyPeptide Group as CEO-elect in April

Reuters February 17, 2021 00:07:22 IST
PolyPeptide names new CEO before likely Swiss IPO during 2021

PolyPeptide names new CEO before likely Swiss IPO during 2021

ZURICH (Reuters) - Privately held drug industry contract manufacturer PolyPeptide Group named a new chief executive on Tuesday ahead of a likely initial public offering (IPO) in Switzerland later this year.

Raymond De Vre, a Belgian who previously worked at Indian contract manufacturer Dr. Reddy's Laboratories as global head of biologics, will join PolyPeptide Group as CEO-elect in April.

CEO Jane Salik is stepping down during the summer but will stay on the board, the Swedish-headquartered company said.

"De Vre is a respected leader in the life sciences community, bringing skills and expertise which will make significant contributions to our continued long-term growth," PolyPeptide said in a statement.

PolyPeptide, a quarter-century-old firm which bought Lonza's peptides business in 2017, is advancing preparations for a 2021 Zurich stock market listing, sources have told Reuters.

The company makes peptides, tiny proteins used among others in cancer drugs, antibiotics, vaccines or anti-wrinkle agents, at plants in Europe, the United States and India.

PolyPeptide's customers include Novavax Inc, for which it is making ingredients for its COVID-19 vaccine candidate.

PolyPeptide did not immediately respond to a request for comment.

(Reporting by John Miller)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Robinhood now a go-to for young investors and short sellers
Business

Robinhood now a go-to for young investors and short sellers

By John McCrank NEW YORK (Reuters) - Robinhood, the online brokerage used by many retail traders to pile in to heavily shorted stocks like GameStop Corp, has made an ambitious push into loaning out its clients' shares to short sellers as it expands its business. The broker had $1.9 billion in shares loaned out as of Dec. 31, nearly three times the $674 million a year earlier, and it was permitted to lend out $4.6 billion worth of securities under margin agreements, around five times bigger than the prior year, according to an annual regulatory filing late on Monday

Wall Street mixed as Apple and Tesla retreat
Business

Wall Street mixed as Apple and Tesla retreat

By Noel Randewich (Reuters) - Wall Street was mixed on Tuesday, with Apple and Tesla losing ground, while materials and energy companies climbed as investors looked toward the U.S. Congress approving another stimulus package.

Biden's SEC nominee vows review of GameStop trading issues, climate disclosures
Business

Biden's SEC nominee vows review of GameStop trading issues, climate disclosures

By Pete Schroeder and Chris Prentice WASHINGTON (Reuters) - U.S. President Joe Biden's pick to head a key market regulator promised on Tuesday a thorough review of issues raised by the GameStop Corp stock frenzy and suggested companies may have to disclose their potential risks from climate change